• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MCF7人乳腺癌对他莫昔芬的反应:采用三点式对比增强磁共振成像方法进行评估

Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method.

作者信息

Furman-Haran E, Grobgeld D, Margalit R, Degani H

机构信息

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Clin Cancer Res. 1998 Oct;4(10):2299-304.

PMID:9796958
Abstract

Variations in the cellular volume fraction and in the microvascular permeability of MCF7 human breast tumors were used to assess response to tamoxifen. These pathophysiological features were mapped by applying the three-time-point, contrast-enhanced, high resolution magnetic resonance imaging method (H. Degani et al, Nat. Med., 3: 780-782, 1997). Short-term treatment with tamoxifen caused a highly significant increase in the fraction of pixels displaying intermediate contrast agent clearance pattern and a significant increase in the fraction of pixels displaying high rate of contrast agent entrance. These changes resulted from a marked rise in the extracellular volume fraction, indicating increased necrosis, and from an augmentation in the microvascular permeability, predominantly in the vicinity of the high extracellular volume fraction areas, as a result of stress-induced angiogenesis.

摘要

通过MCF7人乳腺肿瘤的细胞体积分数和微血管通透性的变化来评估他莫昔芬的疗效。这些病理生理特征通过应用三点对比增强高分辨率磁共振成像方法进行测绘(H. Degani等人,《自然医学》,第3卷,第780 - 782页,1997年)。他莫昔芬短期治疗导致显示中等造影剂清除模式的像素比例显著增加,以及显示高造影剂进入率的像素比例显著增加。这些变化源于细胞外体积分数的显著升高,表明坏死增加,以及微血管通透性的增强,主要发生在高细胞外体积分数区域附近,这是应激诱导血管生成的结果。

相似文献

1
Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method.MCF7人乳腺癌对他莫昔芬的反应:采用三点式对比增强磁共振成像方法进行评估
Clin Cancer Res. 1998 Oct;4(10):2299-304.
2
Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.原位MCF7人乳腺癌中血管内皮生长因子的激素调节
Cancer Res. 2002 Apr 1;62(7):1948-51.
3
Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.他莫昔芬通过抑制内皮生长增强植入的MCF7乳腺癌细胞的死亡。
Cancer Res. 1994 Nov 1;54(21):5511-4.
4
Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.通过动态钆-二乙三胺五乙酸增强弛豫测量法对乳腺肿瘤的血管通透性和细胞外体积分数进行磁共振成像测量。
Magn Reson Imaging. 2007 Apr;25(3):293-302. doi: 10.1016/j.mri.2006.10.016. Epub 2006 Dec 6.
5
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.AG-013736是一种新型的血管内皮生长因子(VEGF)受体酪氨酸激酶抑制剂,通过动态对比增强磁共振成像检测发现,它可抑制乳腺癌生长并降低血管通透性。
Magn Reson Imaging. 2007 Apr;25(3):319-27. doi: 10.1016/j.mri.2006.09.041. Epub 2007 Feb 5.
6
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients.血管生成的测定为预测辅助性他莫昔芬对淋巴结阳性乳腺癌患者的疗效时的雌激素受体状态增添了信息。
Clin Cancer Res. 1996 Jul;2(7):1191-8.
7
Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.使用流量和通透性限制示踪剂对肿瘤灌注进行参数成像。
J Magn Reson Imaging. 2002 Sep;16(3):289-99. doi: 10.1002/jmri.10159.
8
Magnetic resonance imaging of breast cancer angiogenesis: a review.乳腺癌血管生成的磁共振成像:综述
J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):47-54.
9
Parametric imaging of tumor perfusion with deuterium magnetic resonance imaging.利用氘磁共振成像对肿瘤灌注进行参数成像。
Microvasc Res. 2002 Jul;64(1):104-15. doi: 10.1006/mvre.2002.2411.
10
MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
Radiat Med. 1998 Jul-Aug;16(4):315-9.

引用本文的文献

1
Standardization of radiological evaluation of dynamic contrast enhanced MRI: application in breast cancer diagnosis.动态对比增强磁共振成像的放射学评估标准化:在乳腺癌诊断中的应用
Technol Cancer Res Treat. 2014 Oct;13(5):445-54. doi: 10.7785/tcrtexpress.2013.600263. Epub 2013 Aug 31.
2
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.融合正电子发射断层扫描/磁共振乳腺成像的诊断准确性:初步结果。
Br J Radiol. 2011 Feb;84(998):126-35. doi: 10.1259/bjr/93330765. Epub 2010 Oct 19.
3
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
乳腺对比增强磁共振成像中乳腺病变特征定量参数分析的评估
Eur Radiol. 2006 Dec;16(12):2834-41. doi: 10.1007/s00330-006-0348-5. Epub 2006 Jul 29.
4
Application of magnetic resonance imaging to angiogenesis in breast cancer.磁共振成像在乳腺癌血管生成中的应用。
Breast Cancer Res. 2001;3(1):22-7. doi: 10.1186/bcr266.